Hospital Alvaro Cunqueiro — Clinical Trial Site

105 Registered trials

51 Currently recruiting

Organisation

Hospital Alvaro Cunqueiro

Location

Vigo, Spain

Identifier

ORG-100049047

Address

Estrada Clara Campoamor No 341, 36312, Spain

Departments

#034014 Oncología Médica
#2319:servicio de neurología
0659: Servicio de Neurologia
3119: Cardiología
Anestesia
Anestesiología y Reanimación
Cardiología
Cardiology
Cardiology Department
Cardiovascular Research Unit at the University Hospital Complex of Vigo
Cirugía general
Complexo Hospitalario Universitario de Vigo. Servicio de Medicina Interna
Department of Psychiatry
Gastroenterology
Hematología
Hematology
Infectious Diseases
Internal Medicine
Interventional Cardiology
Medica Oncology
Medical Oncology
N/A
NEUROLOFÍA
Neurología
Neurology
Neurology Department
Neurology Pediatrics
Neuropediatric
Oncologia
Oncología Médica
Oncology
Oncology Department
Oncology Service
Pediatrics
Pneumology
Psychiatry
Pulmonology
Servicio de Cardiologia
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de infecciosas
Servicio de Medicina Interna
Servicio de Medicina Interna. Unidad de Enfermedades Infecciosas
Servicio de Neurología
Servicio de Oncología
Servicio de Oncología Médica
Servicio de Oncología y Hematología Pediátricas
SERVICIO DE PSIQUIATRIA
Thoracic Oncology
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva

Clinical trials at this site (105)

Search interface

Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s… Pending

2025-520954-12-00 Atrial Fibrillation Device thrombosis post-Left Atrial 6
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Pending

2025-521388-11-00 Staphylococcus aureus bacteraemia 4
Optimising TREATment for severe Gram-Negative Bacterial infections. Pending

2025-521476-65-00 Severe Gram-Negative Bacterial infections 6
REVITALISE Study Pending

2025-522060-32-00 STEMI (ST elevated Myocardial Infarction) 4
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) - X-CE… Pending

2025-522775-29-00 Depressive episodes associated with Bipolar disorder I 5
An Open-label Study of Azetukalner in Bipolar I or II Depression Pending

2025-522872-10-00 Depressive episodes associated with Bipolar disorder I 5
A Phase 3 Study of Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis Pending

2025-524316-11-00 Primary Progressive Multiple Sclerosis (PPMS) 5
Immunosuppressant Discontinuation in Elderly patients with ulcerative colitis And long-term remission Pending

2025-524675-23-00 Ulcerative Colitis 6
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC Recruiting

2025-522867-13-00 Non Small Cell Lung Cancer 4 2026-04-27
A Phase 2, randomized, multicenter, open-label neoadjuvant study evaluating zanidatamab in combination with chemotherapy in participants wit… Recruiting

2025-523204-68-00 HER2-positive breast cancer 4 2026-03-25
A proof of concept study to evaluate treatments´efficacy by monitoring Minimal Residual Disease using ctDNA in HR-positive/HER2-negative ear… Recruiting

2023-505661-89-00 Early-stage, Hormone Receptor (HR)-positive / Human Epi 4 2025-12-19
Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke Recruiting

2025-522455-26-00 Acute Ischemic Stroke 9 2025-12-17
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab a… Recruiting

2023-505172-29-00 Resectable Non-small Cell Lung Cancer 4 2025-04-24
A Phase 3 Double-blind Study to Evaluate the Efficacy and Safety of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents wi… Recruiting

2022-501332-42-00 Relapsing Remitting Multiple Sclerosis 5 2025-02-26
Randomized Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Ade… Recruiting

2024-513317-12-00 Pancreatic cancer 5 2025-02-05
Renal Adjuvant MultiPle Arm Randomised Trial (RAMPART) Recruiting

2024-513219-29-00 Renal Cell Carcinoma 5 2024-10-21
A Phase 3 Study of Obexelimab in Patients with IgG4-Related Disease Recruiting

2022-500718-24-00 IgG4-Related Disease 5 2023-06-09
A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients with NMDAR or LGI1 mediated autoimm… Recruiting

2023-504226-18-00 NMDAR or LGI1 mediated autoimmune Encephalitis 5 2022-11-30
A study to evaluate the effect of venglustat tablets on left ventricular mass index in male and female adult participants with Fabry disease Recruiting

2023-509715-91-00 Fabry’s disease 5 2022-05-06
AMUNDSEN - Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI)… Recruiting

2024-518195-31-00 acute myocardial infarction 6 2021-09-29
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib in RET fusion-Positive NSCLC Recruiting

2023-506784-33-00 RET fusion-Positive NSCLC 5 2021-01-19
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
Non-inferiority study of frexalimab subcutaneous administration compared to intravenous administration in adult participants with multiple s… Recruiting

2024-519304-28-00 Multiple Sclerosis 5 2026-04-20